Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Characterization of M. catarrhalis iron uptake proteins and their application in vaccine design

FY 2018-19

Summary
Moraxella catarrhalis is a bacterium that normally colonizes the human respiratory and urinary tracts, causing no disease. However, it can be an opportunistic pathogen in individuals with weakened or naïve immune systems. M. catarrhalis causes otitis media and in severe cases, sepsis. The emergence of antimicrobial resistance in M. catarrhalis signify the need for a vaccine against the bacterium as a preventative treatment method. Bacterial iron acquisition proteins are potential targets as vaccine antigens, due to their importance in obtaining iron from host iron carriers, such as transferrin (Tf) and lactoferrin (Lf), to allow for bacterial survival inside the human host. M. catarrhalis iron acquisition proteins include Tf-binding proteins (Tbps) and Lfbinding proteins (Lbps). Lbps are known to contribute to bacterial defense against host antimicrobial peptides. A vaccine designed against M. catarrhalis based on Tbps and Lbps can prevent the bacteria from colonizing and causing disease. In this study, various M. catarrhalis proteins that are essential for iron uptake will be studied through structural genomics, proteomics, and genetic approaches. A thorough understanding of these proteins is important for designing a protective vaccine that is crossprotective against all M. catarrhalis strains and prevent vaccine escape. Furthermore, putative TbpB-based vaccine antigens will be engineered and evaluated for its suitability in a pan-M. catarrhalis vaccine.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406461
Name
Chan Clement K
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of M. catarrhalis iron uptake proteins and their application in vaccine design
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antigen Engineering; Bacterial Iron Uptake; Iron Transport; Lactoferrin Binding Protein; Microbiology; Moraxella Catarrhalis; Proteomics; Structural Biology; Transferrin Binding Protein; Vaccine Design
Abstract
Moraxella catarrhalis is a bacterium that normally colonizes the human respiratory and urinary tracts, causing no disease. However, it can be an opportunistic pathogen in individuals with weakened or naïve immune systems. M. catarrhalis causes otitis media and in severe cases, sepsis. The emergence of antimicrobial resistance in M. catarrhalis signify the need for a vaccine against the bacterium as a preventative treatment method. Bacterial iron acquisition proteins are potential targets as vaccine antigens, due to their importance in obtaining iron from host iron carriers, such as transferrin (Tf) and lactoferrin (Lf), to allow for bacterial survival inside the human host. M. catarrhalis iron acquisition proteins include Tf-binding proteins (Tbps) and Lfbinding proteins (Lbps). Lbps are known to contribute to bacterial defense against host antimicrobial peptides. A vaccine designed against M. catarrhalis based on Tbps and Lbps can prevent the bacteria from colonizing and causing disease. In this study, various M. catarrhalis proteins that are essential for iron uptake will be studied through structural genomics, proteomics, and genetic approaches. A thorough understanding of these proteins is important for designing a protective vaccine that is crossprotective against all M. catarrhalis strains and prevent vaccine escape. Furthermore, putative TbpB-based vaccine antigens will be engineered and evaluated for its suitability in a pan-M. catarrhalis vaccine.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chan, Clement K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~